About PharmaTrain
The aim of the project is to provide courses which are designed to meet the needs of professionals working in medicines development. The main objective of the PharmaTrain project is to harmonize, build and implement modular master level programmes in pharmaceutical medicine / medicines development. These programmes will enable graduates to lead the drug development process, aiming to give Europe a competitive advantage in developing innovative medicines.
The programme enhances career opportunities for graduates by providing education aiming at understanding the industry’s integrative medicines development processes and requirements and allowing individuals to build a portfolio of recognised and transferable credit points in the European Credit, Transfer and Accumulation System (ECTS) in a modular fashion, with the highest achievement of a master degree.
To achieve this, the running project is divided into 8 Work Packages
More detailed information on the PharmaTrain courses and modules can be found on these pages: projects, courses
PharmaTrain is funded by the Innovative Medicines Initiative joint undertaking (IMI JU).
PharmaTrain is one of the 15 projects belonging to the first call launched in 2009. The consortium includes 22 universities and 11 learned societies (33 public partners), 15 EFPIA private partners and 3 advisors. PharmaTrain is funded with 6.6 Mill. Euro (public and private).
The project started on May 1, 2009 and is funded for five years.
